Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Clinicopathological characteristics of TERT promoter mutation and telomere length in hepatocellular carcinoma.

Medicine - 1 Feb 2017

Lee Hye Won, Park Tae In, Jang Se Young, Park Soo Young, Park Won-Jin, Jung Soo-Jung, Lee Jae-Ho

Abstract excerpt

Promoter mutations in telomerase reverse transcriptase (TERT) and telomere length have been studied in various tumors. In the present study, the frequency and clinical characteristics of TERT promoter mutation and telomere length were studied in hepatocellular carcinoma (HCC). TERT promoter mutation and telomere length were analyzed in 162 tumor samples of the patients with HCC by sequencing and real-time PCR,...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Carcinoma, Hepatocellular
Share to Liver Neoplasms

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Prognosis

Share to Promoter Regions, Genetic

Share to Real-Time Polymerase Chain Reaction

Share to Sex Factors

Share to Telomerase

Share to Telomere

Source

Open in PubMed Open full text

Identifiers

PMID: 28151853
DOI: 10.1097/MD.0000000000005766
PMCID: PMC5293416

Genes

TERT

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-07.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Clinicopathological characteristics of TERT promoter mutation and telomere length in hepatocellular carcinoma.PMID 28151853Read ↗

Significance of TERT Genetic Alterations and Telomere Length in Hepatocellular CarcinomaSemantic proximity Read ↗

Telomerase reverse transcriptase promoter mutations in hepatitis B virus-associated hepatocellular carcinoma.Semantic proximity Read ↗

The TERT promoter mutation incidence is modified by germline TERT rs2736098 and rs2736100 polymorphisms in hepatocellular carcinoma.Semantic proximity Read ↗

TERT promoter mutations in primary liver tumors.Semantic proximity Read ↗

Association of TERT promoter mutations with early recurrence in hepatocellular carcinoma: a subgroup analysis in a Vietnamese cohort.Semantic proximity Read ↗

Frequency and geographic distribution of TERT promoter mutations in primary hepatocellular carcinomaSemantic proximity Read ↗

Association of TERT (rs2736098 and rs2736100) genetic variants with elevated risk of hepatocellular carcinoma: a retrospective case-control study.Semantic proximity Read ↗

TERT promoter mutation in resectable hepatocellular carcinomas: a strong association with hepatitis C infection and absence of hepatitis B infection.Semantic proximity Read ↗

Common telomerase reverse transcriptase promoter mutations in hepatocellular carcinomas from different geographical locations.Semantic proximity Read ↗

Association of Tert Promoter Mutations With Early Recurrence in Hepatocellular Carcinoma: A Subgroup Analysis in a Vietnamese CohortSemantic proximity Read ↗

BRAF and TERT promoter mutations: clinical application in thyroid cancer.Semantic proximity Read ↗

TERT promoter mutations in thyroid cancer.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.